Palisade Bio, Inc. SEC filings PALI

Palisade Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 16, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 20, 2026 Dec 31, 2025
ARS Annual report to shareholders Sep 15, 2025 Dec 31, 2024
10-K Annual report Mar 24, 2025 Dec 31, 2024
ARS Annual report to shareholders May 22, 2024 Dec 31, 2023
10-K Annual report Mar 26, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
10-K Annual report Mar 22, 2023 Dec 31, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
10-K Annual report Mar 22, 2021 Dec 31, 2020
10-K Annual report Mar 27, 2020 Dec 31, 2019
10-K Annual report Mar 22, 2019 Dec 31, 2018
10-K Annual report Apr 2, 2018 Dec 31, 2017
10-K Annual report Mar 23, 2017 Dec 31, 2016
10-K Annual report Mar 14, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 10, 2014 Dec 31, 2013
10-K Annual report Mar 15, 2013 Dec 31, 2012
10-K Annual report Mar 30, 2012 Dec 31, 2011

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PALI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1357459
Former names
PALISADE BIO, INC. (until Oct 30, 2026); Seneca Biopharma, Inc. (until Apr 26, 2021); Neuralstem, Inc. (until Jan 23, 2020)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.